Gables Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.09M | Sell |
16,302
-50
| -0.3% | -$5.85K | 0.76% | 33 |
|
|
2026
Q1 | $1.97M | Sell |
16,352
-550
| -3% | -$63.5K | 0.83% | 34 |
|
|
2025
Q4 | $1.78M | Sell |
16,902
-400
| -2% | -$37.5K | 0.75% | 37 |
|
|
2025
Q3 | $1.45M | Buy |
17,302
+275
| +2% | +$22.6K | 0.62% | 42 |
|
|
2025
Q2 | $1.35M | Sell |
17,027
-1,850
| -10% | -$147K | 0.64% | 39 |
|
|
2025
Q1 | $1.69M | Buy |
18,877
+875
| +5% | +$81.7K | 0.84% | 32 |
|
|
2024
Q4 | $1.79M | Buy |
18,002
+450
| +3% | +$46.4K | 0.86% | 31 |
|
|
2024
Q3 | $1.99M | Buy |
17,552
+1,715
| +11% | +$204K | 1.01% | 27 |
|
|
2024
Q2 | $1.96M | Sell |
15,837
-150
| -0.9% | -$19.3K | 1.03% | 26 |
|
|
2024
Q1 | $2.11M | Sell |
15,987
-100
| -0.6% | -$12.3K | 1.16% | 22 |
|
|
2023
Q4 | $1.75M | Sell |
16,087
-95
| -0.6% | -$9.86K | 1.09% | 24 |
|
|
2023
Q3 | $1.67M | Sell |
16,182
-16
| -0.1% | -$1.73K | 1.16% | 24 |
|
|
2023
Q2 | $1.87M | Buy |
16,198
+135
| +0.8% | +$15.3K | 1.22% | 22 |
|
|
2023
Q1 | $1.71M | Buy |
16,063
+43
| +0.3% | +$4.64K | 1.19% | 23 |
|
|
2022
Q4 | $1.78M | Sell |
16,020
-35
| -0.2% | -$3.58K | 1.29% | 21 |
|
|
2022
Q3 | $1.38M | Hold |
16,055
| – | – | 1.11% | 25 |
|
|
2022
Q2 | $1.46M | Buy |
16,055
+150
| +0.9% | +$13.3K | 1.11% | 26 |
|
|
2022
Q1 | $1.3M | Hold |
15,905
| – | – | 0.82% | 36 |
|
|
2021
Q4 | $1.22M | Hold |
15,905
| – | – | 0.73% | 35 |
|
|
2021
Q3 | $1.2M | Sell |
15,905
-80
| -0.5% | -$6.08K | 0.78% | 38 |
|
|
2021
Q2 | $1.24M | Sell |
15,985
-12,144
| -43% | -$903K | 0.85% | 35 |
|
|
2021
Q1 | $2.07M | Sell |
28,129
-1,258
| -4% | -$92.8K | 1.13% | 26 |
|
|
2020
Q4 | $2.29M | Sell |
29,387
-524
| -2% | -$40.1K | 1.34% | 23 |
|
|
2020
Q3 | $2.37M | Sell |
29,911
-125
| -0.4% | -$9.79K | 1.53% | 21 |
|
|
2020
Q2 | $2.22M | Buy |
30,036
+640
| +2% | +$48.2K | 1.54% | 21 |
|
|
2020
Q1 | $2.16M | Buy |
29,396
+854
| +3% | +$67.1K | 1.77% | 17 |
|
|
2019
Q4 | $2.48M | Sell |
28,542
-1,431
| -5% | -$118K | 1.66% | 18 |
|
|
2019
Q3 | $2.41M | Buy |
29,973
+2,987
| +11% | +$239K | 1.7% | 15 |
|
|
2019
Q2 | $2.16M | Buy |
26,986
+1,289
| +5% | +$98.7K | 1.76% | 16 |
|
|
2019
Q1 | $2.04M | Buy |
25,697
+404
| +2% | +$30.2K | 1.64% | 19 |
|
|
2018
Q4 | $1.84M | Sell |
25,293
-786
| -3% | -$55.5K | 1.61% | 19 |
|
|
2018
Q3 | $1.76M | Buy |
26,079
+68
| +0.3% | +$4.33K | 1.34% | 23 |
|
|
2018
Q2 | $1.49M | Buy |
26,011
+686
| +3% | +$38.7K | 1.22% | 26 |
|
|
2018
Q1 | $1.32M | Buy |
+25,325
| New | +$1.37M | 1.16% | 27 |
|
Other funds holding MRK
Gables Capital Management's MRK Position: Q2 2026 in Review
Gables Capital Management reduced its Merck (MRK) stake by 0.31% in Q2 2026, selling an estimated $5.85K and leaving 16,302 shares worth $2.09M. The position accounts for 0.76% of the portfolio, ranked #33.
Gables Capital Management first reported a position in MRK in Q1 2018 and has held it in 34 quarters since. The position peaked at $2.48M in Q4 2019. 3,820 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Gables Capital Management held 16,302 shares of Merck worth $2.09M as of Q2 2026.
- Gables Capital Management sold 50 Merck shares in Q2 2026, an estimated $5.85K.
- Merck made up 0.76% of Gables Capital Management's portfolio in Q2 2026, its #33 holding.
- Gables Capital Management first reported a position in Merck in Q1 2018 and has held it in 34 quarters since.
- Gables Capital Management's Merck position peaked at $2.48M in Q4 2019.
- 3,820 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Gables Capital Management's 13F filing for Q2 2026, filed 10 Aug 2026.